A carbon 21 steroidal metabolite from progestin, 20β‐hydroxy‐5α‐dihydroprogesterone, stimulates the androgen receptor in prostate cancer cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|78|3|222-232

ISSN： 0270-4137

Source： THE PROSTATE, Vol.78, Iss.3, 2018-02, pp. : 222-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen receptor‐interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen‐deficient conditions

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 11, 2015-06 ,pp. : 2535-2545

John Wiley & Sons Inc

Access to resources Recommend Favorite

The transcriptional programme of the androgen receptor (AR) in prostate cancer

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 358-366

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells

By  

THE PROSTATE, Vol. 73, Iss. 12, 2013-09 ,pp. : 1306-1315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hsa‐miR‐146a‐5p modulates androgen‐independent prostate cancer cells apoptosis by targeting ROCK1

By  

THE PROSTATE, Vol. 75, Iss. 16, 2015-12 ,pp. : 1896-1903

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of an Androgen Receptor Polymorphism in the Clinical Outcome of Patients with Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 68, Iss. 1, 2002-01 ,pp. : 16-23

Karger

Access to resources Recommend Favorite